Trademark: 77212184
Word
C
Status
Registered
Status Code
800
Status Date
Friday, October 4, 2019
Serial Number
77212184
Registration Number
3849207
Registration Date
Tuesday, September 21, 2010
Mark Type
3000
Filing Date
Thursday, June 21, 2007
Published for Opposition
Tuesday, November 17, 2009

Trademark Owner History

Classifications
1 Chemicals used in industry and science, diagnostic preparations, reagents and chemical test kits comprised of reagents for chemical analyses and reagents for medical research use for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant conditions, malignant conditions, cancer and inborn errors for scientific or research use
5 Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents and kits comprised of medical diagnostic reagents and assays for detection of cancer and neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn errors; medical diagnostic preparations, namely, in-vitro and in-vivo diagnostic test kits, diagnostic immunocytochemical kits, diagnostic immunohistochemical kits, diagnostic histology kits, diagnostic cytology kits, diagnostic liquid-immuno-assay kits, diagnostic solid-phase immuno-assay kits, diagnostic strip-tests, diagnostic dip-stick-tests, point of care tests, diagnostic lateral-flow assay kits, diagnostic flow-through assay kits, diagnostic immuno-chromatographic kits, all of the above-mentioned kits being for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases; medical diagnostic test strips and diagnostic dip-stick tests for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases
10 [ Diagnostic testing machines, namely, point-of-care testing machines, diagnostic liquid-immuno-assay machines, diagnostic immunocytochemical machines, diagnostic immunohistochemical machines, diagnostic histology machines, diagnostic cytology machines, diagnostic solid-phase immuno assay machines, diagnostic ELISA testing machines, diagnostic immuno-chromatographic machines, all of the aforementioned machines being used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic equipment, namely, containers specially designed for storing and transporting medical samples in the nature of tubes, multiwell plates, columns, strips, sticks, brushes, all for sampling of medical samples from body cavities and epithelia; medical syringes, needles for medical use, spatulas for medical samples and medical diagnostic testing, and medical diagnostic testing swabs, cloths, tampons, all for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative and vascular diseases as indicated above; diagnostic nucleic acid detection machines, diagnostic nucleic acid amplification machines, diagnostic immuno-histology machines and diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic apparatuses and instruments, namely, hand-held, table-top and floor-standing centrifugal, gravitational-separating, electrophoretic, chromatographic, conductometric, potentiometric, spectrometric, spectro-photometric, radiologic electromagnetic-resonance, histological, microscopic and in-vivo-imaging machines and apparatuses for use in preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative and vascular diseases as indicated above for clinical and medical laboratory use ]
42 [ Scientific and technological services and research and design relating thereto, industrial analysis and research services, design and development of computer hardware and software, scientific analysis in the fields of chemistry, biology and molecular biology, laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceutical, chemical and diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services ]
44 Medical services, veterinary services, medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds
Color is not claimed as a feature of the mark.
The mark consists of a stylized letter "C" with a vertical line passing through it, with the letter "C" being blurred to the left of the line and clear or in focus to the right of the vertical line.

Trademark Events
Oct 9, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 9, 2020
Teas Change Of Correspondence Received
Oct 9, 2020
Teas Change Of Domestic Representatives Address
Oct 9, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 9, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 9, 2020
Teas Change Of Owner Address Received
Oct 5, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 5, 2020
Teas Change Of Correspondence Received
Oct 5, 2020
Teas Change Of Domestic Representatives Address
Oct 5, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 5, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 5, 2020
Teas Change Of Owner Address Received
Dec 10, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 10, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 4, 2019
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Oct 4, 2019
Registered And Renewed (First Renewal - 10 Yrs)
Oct 4, 2019
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Oct 2, 2019
Teas Section 8 & 9 Received
Oct 2, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 2, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 21, 2019
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Jan 10, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 10, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 6, 2017
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
May 6, 2017
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
May 5, 2017
Case Assigned To Post Registration Paralegal
Mar 20, 2017
Teas Section 8 & 15 Received
Mar 24, 2014
Withdrawal Of Attorney Granted
Mar 24, 2014
Teas Withdrawal Of Attorney Received
Apr 20, 2012
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 20, 2012
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 18, 2012
Automatic Update Of Assignment Of Ownership
Sep 21, 2010
Registered-Principal Register
Aug 14, 2010
1(B) Basis Deleted; Proceed To Registration
Aug 9, 2010
Notice Of Allowance Cancelled
Aug 10, 2010
Case Assigned To Intent To Use Paralegal
Aug 9, 2010
Teas Delete 1(B) Basis Received
Feb 9, 2010
Noa Mailed - Sou Required From Applicant
Nov 17, 2009
Official Gazette Publication Confirmation E-Mailed
Nov 17, 2009
Published For Opposition
Oct 9, 2009
Law Office Publication Review Completed
Oct 7, 2009
Assigned To Lie
Oct 6, 2009
Approved For Pub - Principal Register
Oct 6, 2009
Data Modification Completed
Oct 4, 2009
Previous Allowance Count Withdrawn
Oct 4, 2009
Approved For Pub - Principal Register
Oct 2, 2009
Teas/Email Correspondence Entered
Sep 30, 2009
Correspondence Received In Law Office
Sep 30, 2009
Teas Response To Suspension Inquiry Received
Mar 31, 2009
Notification Of Inquiry As To Suspension E-Mailed
Mar 31, 2009
Inquiry To Suspension E-Mailed
Mar 31, 2009
Suspension Inquiry Written
Mar 31, 2009
Lie Checked Susp - To Atty For Action
Sep 29, 2008
Notification Of Letter Of Suspension E-Mailed
Sep 29, 2008
Letter Of Suspension E-Mailed
Sep 29, 2008
Suspension Letter Written
May 6, 2008
Teas/Email Correspondence Entered
May 5, 2008
Correspondence Received In Law Office
May 6, 2008
Assigned To Lie
May 5, 2008
Teas Response To Office Action Received
Nov 4, 2007
Notification Of Non-Final Action E-Mailed
Nov 4, 2007
Non-Final Action E-Mailed
Nov 4, 2007
Non-Final Action Written
Sep 24, 2007
Assigned To Examiner
Jun 26, 2007
Notice Of Design Search Code Mailed
Jun 25, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24